AstraZeneca to invest $2.5 billion in new Beijing R&D center
Astrazeneca will invest $ 2.5 billion in New Beijing R & D
Report
User X, known as “Gujju Tweeter”, recently sparked a debate online with a post contrasting his…
Palantir Technologies (NASDAQ: PLTR) Stock investors got some good news to start their weekend at 8pm…
The Federal Reserve cut its target interest rate three times in late 2024, meaning savings rates…
“The growth of the private sector is weak, immigration slows down slowly, and geopolitical uncertainties remain.”…
Ziprocruiter svp Bartolome Lora sells $ 12,861 in shares Report Thank you for Report Game…
The dollar is defensive because Trump tariffs cause fuel economic worries Report Thank you for…